A case of rheumatoid arthritis with bucillamine-induced yellow nail syndrome initially manifesting as pulmonary disease.

作者信息

Isozaki Takeo, Yajima Nobuyuki, Sato Michihito, Takahashi Ryo, Wakabayashi Kuninobu, Miwa Yusuke, Negishi Masao, Ide Hirotsugu, Kasama Tsuyoshi

机构信息

Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo 142-8666, Japan.

出版信息

Clin Med Insights Case Rep. 2010;3:63-8. doi: 10.4137/CCRep.S5514. Epub 2010 Oct 14.

DOI:10.4137/CCRep.S5514

PMID:21769257

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3046014/

Abstract

We report a case of a 67-year-old woman with rheumatoid arthritis with yellow nail syndrome (YNS) that was caused by bucillamine. All three signs (yellow fingernails, lymphatic edema, and bronchiectasis) of YNS manifested, with characteristic timing, first with the nails turning yellow after when bronchiectasis was noticed. We reviewed 10 case reports from Japan and compared the periods until the appearance of yellow nails after starting bucillamine treatment, as well as those until lung disease and leg edema appeared.

摘要